Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2020

Open Access 01-12-2020 | Myocardial Infarction | Research article

Differential leukocyte counts and cardiovascular mortality in very old patients with acute myocardial infarction: a Chinese cohort study

Authors: Xiao-Ni Yan, Jing-Lu Jin, Meng Zhang, Li-Feng Hong, Yuan-Lin Guo, Na-Qiong Wu, Cheng-Gang Zhu, Qian Dong, Jian-Jun Li

Published in: BMC Cardiovascular Disorders | Issue 1/2020

Login to get access

Abstract

Background

Total leukocyte and differential Leukocyte counts are prognostic indictors in patients with coronary artery disease (CAD). However, there is no data available regarding their prognostic utility in very old patients with acute myocardial infarction (AMI). The aim of this study is to investigate the potential role of different leukocyte parameters in predicting the mortality among very old patients with AMI.

Methods

A total of 523 patients aged over 80 years with AMI were consecutively enrolled into this study. Leukocyte and its subtypes were obtained at admission in each patient. The primary study endpoint was cardiovascular mortality. Patients were followed up for an average of 2.2 years and 153 patients died. The associations of leukocyte parameters with mortality were assessed using Cox regression analyses. The concordance index was calculated to test the model efficiency.

Results

In multivariable regression analysis, neutrophils-plus-monocytes-to-lymphocytes ratio (NMLR) and neutrophils-to-lymphocytes ratio (NLR) were two most significant predictors of mortality among all the leukocyte parameters (HR = 3.21, 95% CI 1.75–5.35; HR = 2.79, 95% CI 1.59–4.88, respectively, all p < 0.001, adjusted for age, male gender, body mass index, family history of CAD, smoking, hypertension, diabetes mellitus, high-density lipoprotein cholesterol (HDL-C), non-HDL-C, high sensitivity C-reactive protein, creatinine, left ventricular ejection fraction, troponin I, use of statin, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, and percutaneous coronary intervention). Furthermore, adding NMLR and NLR into the Cox model increased the C-statistic by 0.038 and 0.037 respectively, which were more significant than that of other leukocyte parameters. Besides, addition of NMLR and NLR to the Canada Acute Coronary Syndrome Risk Score model also increased the C-statistic by 0.079 and 0.077 respectively.

Conclusion

Our data firstly indicated that most leukocyte subtypes were independent markers for the mortality in very old patients with AMI, while NMLR and NLR appeared to be more effective.
Appendix
Available only for authorised users
Literature
1.
go back to reference Johansson S, Rosengren A, Young K, Jennings E. Mortality and morbidity trends after the first year in survivors of acute myocardial infarction: a systematic review. BMC Cardiovasc Disord. 2017;17(1):53.CrossRef Johansson S, Rosengren A, Young K, Jennings E. Mortality and morbidity trends after the first year in survivors of acute myocardial infarction: a systematic review. BMC Cardiovasc Disord. 2017;17(1):53.CrossRef
2.
go back to reference Shiraki T, Saito D. Clinical features of acute myocardial infarction in elderly patients. Acta Med Okayama. 2011;65(6):379–85.PubMed Shiraki T, Saito D. Clinical features of acute myocardial infarction in elderly patients. Acta Med Okayama. 2011;65(6):379–85.PubMed
3.
go back to reference Marrugat J, Sala J, Manresa JM, Gil M, Elosua R, Perez G, Albert X, Pena A, Masia R. Acute myocardial infarction population incidence and in-hospital management factors associated to 28-day case-fatality in the 65 year and older. Eur J Epidemiol. 2004;19(3):231–7.CrossRef Marrugat J, Sala J, Manresa JM, Gil M, Elosua R, Perez G, Albert X, Pena A, Masia R. Acute myocardial infarction population incidence and in-hospital management factors associated to 28-day case-fatality in the 65 year and older. Eur J Epidemiol. 2004;19(3):231–7.CrossRef
4.
go back to reference Kanic V, Vollrath M, Tapajner A, Sinkovic A. Sex-related 30-day and long-term mortality in acute myocardial infarction patients treated with percutaneous coronary intervention. J Womens Health (Larchmt). 2017;26(4):374–9.CrossRef Kanic V, Vollrath M, Tapajner A, Sinkovic A. Sex-related 30-day and long-term mortality in acute myocardial infarction patients treated with percutaneous coronary intervention. J Womens Health (Larchmt). 2017;26(4):374–9.CrossRef
5.
go back to reference Haller PM, Jager B, Farhan S, Christ G, Schreiber W, Weidinger F, Stefenelli T, Delle-Karth G, Kaff A, Maurer G, et al. Impact of age on short- and long-term mortality of patients with ST-elevation myocardial infarction in the VIENNA STEMI network. Wien Klin Wochenschr. 2018;130(5–6):172–81.CrossRef Haller PM, Jager B, Farhan S, Christ G, Schreiber W, Weidinger F, Stefenelli T, Delle-Karth G, Kaff A, Maurer G, et al. Impact of age on short- and long-term mortality of patients with ST-elevation myocardial infarction in the VIENNA STEMI network. Wien Klin Wochenschr. 2018;130(5–6):172–81.CrossRef
6.
go back to reference Cui Y, Hao K, Takahashi J, Miyata S, Shindo T, Nishimiya K, Kikuchi Y, Tsuburaya R, Matsumoto Y, Ito K, et al. Age-specific trends in the incidence and in-hospital mortality of acute myocardial infarction over 30 years in Japan-report from the Miyagi AMI Registry Study. Circ J. 2017;81(4):520–8.CrossRef Cui Y, Hao K, Takahashi J, Miyata S, Shindo T, Nishimiya K, Kikuchi Y, Tsuburaya R, Matsumoto Y, Ito K, et al. Age-specific trends in the incidence and in-hospital mortality of acute myocardial infarction over 30 years in Japan-report from the Miyagi AMI Registry Study. Circ J. 2017;81(4):520–8.CrossRef
7.
go back to reference Sabatine MS, Morrow DA, de Lemos JA, Gibson CM, Murphy SA, Rifai N, McCabe C, Antman EM, Cannon CP, Braunwald E. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation. 2002;105(15):1760–3.CrossRef Sabatine MS, Morrow DA, de Lemos JA, Gibson CM, Murphy SA, Rifai N, McCabe C, Antman EM, Cannon CP, Braunwald E. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation. 2002;105(15):1760–3.CrossRef
8.
go back to reference Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA. 1998;279(18):1477–82.CrossRef Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA. 1998;279(18):1477–82.CrossRef
9.
go back to reference Rana JS, Boekholdt SM, Ridker PM, Jukema JW, Luben R, Bingham SA, Day NE, Wareham NJ, Kastelein JJ, Khaw KT. Differential leucocyte count and the risk of future coronary artery disease in healthy men and women: the EPIC-Norfolk Prospective Population Study. J Intern Med. 2007;262(6):678–89.CrossRef Rana JS, Boekholdt SM, Ridker PM, Jukema JW, Luben R, Bingham SA, Day NE, Wareham NJ, Kastelein JJ, Khaw KT. Differential leucocyte count and the risk of future coronary artery disease in healthy men and women: the EPIC-Norfolk Prospective Population Study. J Intern Med. 2007;262(6):678–89.CrossRef
10.
go back to reference Margolis KL, Manson JE, Greenland P, Rodabough RJ, Bray PF, Safford M, Grimm RH Jr, Howard BV, Assaf AR, Prentice R. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women’s Health Initiative Observational Study. Arch Intern Med. 2005;165(5):500–8.CrossRef Margolis KL, Manson JE, Greenland P, Rodabough RJ, Bray PF, Safford M, Grimm RH Jr, Howard BV, Assaf AR, Prentice R. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women’s Health Initiative Observational Study. Arch Intern Med. 2005;165(5):500–8.CrossRef
11.
go back to reference Amaro A, Gonzalez-Juanatey JR, Iglesias C, Martinez-Sande L, Trillo R, Garcia-Acuna J, Gil de la Pena M. Leukocyte count as a predictor of the severity ischaemic heart disease as evaluated by coronary angiography. Rev Port Cardiol. 1993;12(11):913–7. Amaro A, Gonzalez-Juanatey JR, Iglesias C, Martinez-Sande L, Trillo R, Garcia-Acuna J, Gil de la Pena M. Leukocyte count as a predictor of the severity ischaemic heart disease as evaluated by coronary angiography. Rev Port Cardiol. 1993;12(11):913–7.
12.
go back to reference Hong LF, Li XL, Luo SH, Guo YL, Liu J, Zhu CG, Qing P, Xu RX, Wu NQ, Jiang LX, et al. Relation of leukocytes and its subsets counts with the severity of stable coronary artery disease in patients with diabetic mellitus. PLoS ONE. 2014;9(3):e90663.CrossRef Hong LF, Li XL, Luo SH, Guo YL, Liu J, Zhu CG, Qing P, Xu RX, Wu NQ, Jiang LX, et al. Relation of leukocytes and its subsets counts with the severity of stable coronary artery disease in patients with diabetic mellitus. PLoS ONE. 2014;9(3):e90663.CrossRef
13.
go back to reference Chia S, Nagurney JT, Brown DF, Raffel OC, Bamberg F, Senatore F, Wackers FJ, Jang IK. Association of leukocyte and neutrophil counts with infarct size, left ventricular function and outcomes after percutaneous coronary intervention for ST-elevation myocardial infarction. Am J Cardiol. 2009;103(3):333–7.CrossRef Chia S, Nagurney JT, Brown DF, Raffel OC, Bamberg F, Senatore F, Wackers FJ, Jang IK. Association of leukocyte and neutrophil counts with infarct size, left ventricular function and outcomes after percutaneous coronary intervention for ST-elevation myocardial infarction. Am J Cardiol. 2009;103(3):333–7.CrossRef
14.
go back to reference Sabatine MS, Morrow DA, Cannon CP, Murphy SA, Demopoulos LA, DiBattiste PM, McCabe CH, Braunwald E, Gibson CM. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction 18 trial) substudy. J Am Coll Cardiol. 2002;40(10):1761–8.CrossRef Sabatine MS, Morrow DA, Cannon CP, Murphy SA, Demopoulos LA, DiBattiste PM, McCabe CH, Braunwald E, Gibson CM. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction 18 trial) substudy. J Am Coll Cardiol. 2002;40(10):1761–8.CrossRef
15.
go back to reference Cannon CP, McCabe CH, Wilcox RG, Bentley JH, Braunwald E. Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris, OPUS-TIMI 16 Investigators. Am J Cardiol. 2001;87(5):636–9.CrossRef Cannon CP, McCabe CH, Wilcox RG, Bentley JH, Braunwald E. Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris, OPUS-TIMI 16 Investigators. Am J Cardiol. 2001;87(5):636–9.CrossRef
16.
go back to reference Menon V, Lessard D, Yarzebski J, Furman MI, Gore JM, Goldberg RJ. Leukocytosis and adverse hospital outcomes after acute myocardial infarction. Am J Cardiol. 2003;92(4):368–72.CrossRef Menon V, Lessard D, Yarzebski J, Furman MI, Gore JM, Goldberg RJ. Leukocytosis and adverse hospital outcomes after acute myocardial infarction. Am J Cardiol. 2003;92(4):368–72.CrossRef
17.
go back to reference Mueller C, Neumann FJ, Perruchoud AP, Buettner HJ. White blood cell count and long term mortality after non-ST elevation acute coronary syndrome treated with very early revascularisation. Heart. 2003;89(4):389–92.CrossRef Mueller C, Neumann FJ, Perruchoud AP, Buettner HJ. White blood cell count and long term mortality after non-ST elevation acute coronary syndrome treated with very early revascularisation. Heart. 2003;89(4):389–92.CrossRef
18.
go back to reference Hajj-Ali R, Zareba W, Ezzeddine R, Moss AJ. Relation of the leukocyte count to recurrent cardiac events in stable patients after acute myocardial infarction. Am J Cardiol. 2001;88(11):1221–4.CrossRef Hajj-Ali R, Zareba W, Ezzeddine R, Moss AJ. Relation of the leukocyte count to recurrent cardiac events in stable patients after acute myocardial infarction. Am J Cardiol. 2001;88(11):1221–4.CrossRef
19.
go back to reference Dragu R, Khoury S, Zuckerman R, Suleiman M, Mutlak D, Agmon Y, Kapeliovich M, Beyar R, Markiewicz W, Hammerman H, et al. Predictive value of white blood cell subtypes for long-term outcome following myocardial infarction. Atherosclerosis. 2008;196(1):405–12.CrossRef Dragu R, Khoury S, Zuckerman R, Suleiman M, Mutlak D, Agmon Y, Kapeliovich M, Beyar R, Markiewicz W, Hammerman H, et al. Predictive value of white blood cell subtypes for long-term outcome following myocardial infarction. Atherosclerosis. 2008;196(1):405–12.CrossRef
20.
go back to reference Shiyovich A, Gilutz H, Plakht Y. White blood cell subtypes are associated with a greater long-term risk of death after acute myocardial infarction. Tex Heart Inst J. 2017;44(3):176–88.CrossRef Shiyovich A, Gilutz H, Plakht Y. White blood cell subtypes are associated with a greater long-term risk of death after acute myocardial infarction. Tex Heart Inst J. 2017;44(3):176–88.CrossRef
21.
go back to reference Huynh T, Kouz S, Yan AT, Danchin N, O’Loughlin J, Schampaert E, Yan RT, Rinfret S, Tardif JC, Eisenberg MJ, et al. Canada Acute Coronary Syndrome Risk Score: a new risk score for early prognostication in acute coronary syndromes. Am Heart J. 2013;166(1):58–63.CrossRef Huynh T, Kouz S, Yan AT, Danchin N, O’Loughlin J, Schampaert E, Yan RT, Rinfret S, Tardif JC, Eisenberg MJ, et al. Canada Acute Coronary Syndrome Risk Score: a new risk score for early prognostication in acute coronary syndromes. Am Heart J. 2013;166(1):58–63.CrossRef
22.
go back to reference Zhou BY, Guo YL, Wu NQ, Zhu CG, Gao Y, Qing P, Li XL, Wang Y, Dong Q, Liu G, et al. Plasma big endothelin-1 levels at admission and future cardiovascular outcomes: a cohort study in patients with stable coronary artery disease. Int J Cardiol. 2017;230:76–9.CrossRef Zhou BY, Guo YL, Wu NQ, Zhu CG, Gao Y, Qing P, Li XL, Wang Y, Dong Q, Liu G, et al. Plasma big endothelin-1 levels at admission and future cardiovascular outcomes: a cohort study in patients with stable coronary artery disease. Int J Cardiol. 2017;230:76–9.CrossRef
23.
go back to reference Thiemann DR, Coresh J, Oetgen WJ, Powe NR. The association between hospital volume and survival after acute myocardial infarction in elderly patients. N Engl J Med. 1999;340(21):1640–8.CrossRef Thiemann DR, Coresh J, Oetgen WJ, Powe NR. The association between hospital volume and survival after acute myocardial infarction in elderly patients. N Engl J Med. 1999;340(21):1640–8.CrossRef
24.
go back to reference Vazquez-Oliva G, Zamora A, Ramos R, Marti R, Subirana I, Grau M, Degano IR, Marrugat J, Elosua R. Acute myocardial infarction population incidence and mortality rates, and 28-day case-fatality in older adults. REGICOR Study Rev Esp Cardiol (Engl Ed). 2018;71(9):718–25.CrossRef Vazquez-Oliva G, Zamora A, Ramos R, Marti R, Subirana I, Grau M, Degano IR, Marrugat J, Elosua R. Acute myocardial infarction population incidence and mortality rates, and 28-day case-fatality in older adults. REGICOR Study Rev Esp Cardiol (Engl Ed). 2018;71(9):718–25.CrossRef
25.
go back to reference Azab B, Zaher M, Weiserbs KF, Torbey E, Lacossiere K, Gaddam S, Gobunsuy R, Jadonath S, Baldari D, McCord D, et al. Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction. Am J Cardiol. 2010;106(4):470–6.CrossRef Azab B, Zaher M, Weiserbs KF, Torbey E, Lacossiere K, Gaddam S, Gobunsuy R, Jadonath S, Baldari D, McCord D, et al. Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction. Am J Cardiol. 2010;106(4):470–6.CrossRef
26.
go back to reference O’Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61(4):e78–140.CrossRef O’Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61(4):e78–140.CrossRef
27.
go back to reference Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119–77.CrossRef Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119–77.CrossRef
28.
go back to reference Baldus S, Heeschen C, Meinertz T, Zeiher AM, Eiserich JP, Munzel T, Simoons ML, Hamm CW. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation. 2003;108(12):1440–5.CrossRef Baldus S, Heeschen C, Meinertz T, Zeiher AM, Eiserich JP, Munzel T, Simoons ML, Hamm CW. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation. 2003;108(12):1440–5.CrossRef
29.
go back to reference Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res. 2002;53(1):31–47.CrossRef Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res. 2002;53(1):31–47.CrossRef
30.
go back to reference Bain RJ, Fox JP, Jagger J, Davies MK, Littler WA, Murray RG. Serum cortisol levels predict infarct size and patient mortality. Int J Cardiol. 1992;37(2):145–50.CrossRef Bain RJ, Fox JP, Jagger J, Davies MK, Littler WA, Murray RG. Serum cortisol levels predict infarct size and patient mortality. Int J Cardiol. 1992;37(2):145–50.CrossRef
31.
go back to reference Horne BD, Anderson JL, John JM, Weaver A, Bair TL, Jensen KR, Renlund DG, Muhlestein JB. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol. 2005;45(10):1638–43.CrossRef Horne BD, Anderson JL, John JM, Weaver A, Bair TL, Jensen KR, Renlund DG, Muhlestein JB. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol. 2005;45(10):1638–43.CrossRef
Metadata
Title
Differential leukocyte counts and cardiovascular mortality in very old patients with acute myocardial infarction: a Chinese cohort study
Authors
Xiao-Ni Yan
Jing-Lu Jin
Meng Zhang
Li-Feng Hong
Yuan-Lin Guo
Na-Qiong Wu
Cheng-Gang Zhu
Qian Dong
Jian-Jun Li
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2020
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-020-01743-3

Other articles of this Issue 1/2020

BMC Cardiovascular Disorders 1/2020 Go to the issue